Korean Scientists Just Quietly Confirmed a COVID Vaccine Nightmare
The data is in. This isn't a conspiracy theory anymore.
This article originally appeared on Focal Points and was republished with permission.
Guest post by Nicolas Hulscher, MPH
The study titled, Broad-Spectrum Adverse Events of Special Interests Based on Immune Response Following COVID-19 Vaccination: A Large-Scale Population-Based Cohort Study, was recently published in the Journal of Clinical Medicine:
Background/Objectives: Current studies on adverse events related to the COVID-19 vaccine have predominantly focused on severe, life-threatening side effects. However, numerous less severe but common adverse events (AEs) remain underreported and insufficiently investigated despite their potential impact.
Methods: This population-based cohort study investigated the cumulative incidence rate (cIR) and risk of the broad-spectrum AEs of special interests (AESIs) based on immune response, including gynecological, dermatological, ophthalmological, otologic, and dental problems, following COVID-19 vaccination.
Results: Among 4,203,887 individuals in Seoul, South Korea, the final analysis included 1,458,557 vaccinated subjects and 289,579 non-vaccinated subjects after the exclusion of underlying diseases. The cIR of AESIs for three months was significantly higher in vaccinated subjects than in non-vaccinated subjects, except for endometriosis. The vaccination significantly increased the risks of all the AESIs except for visual impairment. The risk of alopecia showed the highest HRs (HR [95% CI] = 2.40 [1.90–3.03]) among the AESIs following COVID-19 vaccination. Among the vaccinated subjects, heterologous vaccination was associated with the increased risk of most of the AESIs.
Conclusions: Our findings suggest that clinicians should closely recognize and follow up on various COVID-19 vaccine-related AEs due to their unknown impact, even if they may not be serious at present.
Among a massive sample size of 1,748,136 Korean individuals, COVID-19 vaccination significantly increased the risk of the following, previously insufficiently investigated adverse events (Note than some of the HRs below are only mentioned in Figure 2 and not in text, meaning that they were visually estimated):
Alopecia (Hair Loss)
HR: 2.40 (95% CI: 1.90–3.03)
Vaccinated individuals were 2.4 times more likely to develop hair loss than those who were not vaccinated.
Inner Ear Diseases (Hearing & Balance Issues)
HR: 2.37 (95% CI: 2.15–2.60)
The risk of inner ear problems—such as dizziness, vertigo, or hearing loss—was 2.37 times higher after vaccination.
Herpes Zoster (Shingles)
HR: 2.34 (95% CI: 2.12–2.57)
Vaccinated individuals had over twice the risk of developing shingles, a reactivation of latent varicella-zoster virus.
Warts (Viral Skin Growths)
HR: 2.20 (95% CI: 1.95–2.60)
Vaccinated individuals were estimated to be over twice as likely to develop warts, suggesting immune dysregulation.
Menstrual Disorders (Irregular Bleeding & Cycles)
HR: 2.16 (95% CI: 1.96–2.37)
The likelihood of menstrual abnormalities—including heavy bleeding, missed periods, and cycle irregularity—more than doubled post-vaccination.
Middle Ear Diseases (Otitis Media, Infections)
HR: 2.08 (95% CI: 1.75–2.47)
Vaccinated individuals experienced more than a two-fold increase in risk of middle ear infections and related complications.
Tinnitus (Ringing in the Ears)
HR: 1.75 (95% CI: 1.50–2.20)
The risk of developing persistent or intermittent ear ringing was significantly higher in vaccinated individuals.
Periodontal Disease (Gum Disease)
HR: 2.05 (95% CI: 1.45–3.00)
COVID-19 vaccination was associated with a two-fold higher risk of developing gum inflammation and related dental issues.
Glaucoma (Eye Pressure & Vision Loss Risk)
HR: 1.86 (95% CI: 1.66–2.09)
The risk of glaucoma—a condition that can lead to vision loss—increased notably following vaccination.
Bruising (Non-Tender, Yellow Skin Discoloration)
HR: 1.78 (95% CI: 1.27–2.49)
Vaccinated individuals had a significantly higher risk of unexplained bruising, potentially reflecting immune-mediated vascular effects.
Endometriosis (Pelvic Pain & Infertility Risk)
HR: 1.50 (95% CI: 1.25–1.79)
A 50% increased risk of endometriosis was observed in vaccinated women, highlighting possible hormonal or inflammatory pathways.
Visual Impairment (Blurred or Reduced Vision)
HR: 3.94 (95% CI: 0.94–16.41)
Although the point estimate suggests a nearly 4-fold increased risk, the wide confidence interval renders this finding statistically insignificant.
While most studies have focused primarily on serious adverse events following COVID-19 vaccination, many have overlooked a wide range of broad-spectrum side effects.
It's important to recognize that although these adverse events are classified as “non-serious,” they may in fact represent early manifestations of more serious underlying syndromes.
As time progresses and more data accumulates, COVID-19 vaccines are emerging as one of the most dangerous products ever approved by our regulatory agencies.
Epidemiologist and Foundation Administrator, McCullough Foundation
www.mcculloughfnd.org
Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.
Copyright 2025 Focal Points
Preach!